Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Trading Update

30 Jan 2014 07:00

RNS Number : 8428Y
Spectra Systems Corporation
30 January 2014
 



January 30, 2014

 

Spectra Systems Corporation

("Spectra Systems" or the "Company")

G8 Central Bank New Generation Materials and Sensor Program Cancellation and Trading Update

The Board is disappointed that a G8 central bank customer which has been funding the materials and sensor development for a new generation technology has notified the Company that it has decided to cancel this program. To date the company has demonstrated a functional sensor prototype and has had numerous successful trials of the material incorporated in the embodiment of use by the central bank.

Spectra Systems continues to own all of the developed intellectual property, specific covert materials and sensor designs developed under this program. In addition, it expects that the specific materials and data will be unclassified and will be available to the Company to use commercially with another central bank customer.

Importantly the Board is pleased to announce that phosphour sales have in the last three months recovered to levels not experienced since 2011.

In addition it expects Spectra System's performance for the year ended 31 December 2013 to be in line with market expectations. The Board expects to release the Company's preliminary results for the year ended 31 December 2013 in April 2014.

 

Nabil Lawandy, Spectra System's CEO, stated:

"The manner in which this program came to an abrupt halt is gravely disappointing and a loss to the central bank which has spent over $1MM in development of materials and sensor design. Trials were performed over the last year with success and in the last technical discussions, enthusiasm was evident for the project and the success in the refinements made over the last year. In fact, a final large scale test before incorporation into banknotes had been scheduled for 24 February of this year.

We are now free to take this fully completed technology to other central banks as a ready package paid for by the central bank rather than shareholders. We will pursue this aggressively.

In the meantime, this will have minimal impact on market expectations as only negligible revenues relating thereto had been anticipated in such expectations. In addition, this decision by the G8 central bank is not expected to have any impact on current generation business with the central bank to whom we will continue to deliver upgraded sensors throughout the year.

Whilst this news is disappointing, the Board is delighted that phosphour sales have recovered to previous levels."

 

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAFNADPLEAF
Date   Source Headline
22nd Feb 20199:04 amRNSDirector/PDMR Shareholding
19th Feb 201911:38 amRNSRemoval of Reg S restrictions from common stock
19th Feb 20197:00 amRNSDate of Audited Results
22nd Jan 20197:00 amRNSSensor Service Contract
11th Jan 20197:15 amRNSExercise of Options and Director/PDMR Shareholding
9th Jan 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
2nd Jan 20197:00 amRNSFirst Orders for TruBrand in China
19th Dec 20184:16 pmRNSRemoval of Reg S restrictions from common stock
17th Dec 20187:00 amRNSChange of Registered Office
10th Dec 20187:44 amRNSTrading Update: Additional phosphour orders
20th Nov 20183:48 pmRNSExercise of Options
10th Oct 20182:37 pmRNSHolding(s) in Company
24th Sep 20187:00 amRNSInterim Results - Six Months End 30 June 2018
12th Sep 20189:58 amRNSRemoval of Reg S restrictions from common stock
3rd Sep 20187:00 amRNSTwo New Lottery Wins and Results Date
31st May 20184:03 pmRNSRemoval of Reg S restrictions from common stock
14th May 20187:00 amRNSG20 Central Bank begins Funding Sensor Development
24th Apr 20184:32 pmRNSPosting of Annual Report and Accounts
11th Apr 20187:00 amRNSExercise of Options
19th Mar 20187:00 amRNSPreliminary Results
1st Feb 20184:40 pmRNSSecond Price Monitoring Extn
1st Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20187:00 amRNSTrading Update
15th Jan 20187:00 amRNSLicensing Agreement and Supply Agreement
11th Dec 20177:00 amRNSAnnual General Meeting Postponed
10th Nov 20174:32 pmRNSHolding(s) in Company
23rd Oct 20173:44 pmRNSExercise of Options
16th Oct 20177:00 amRNSTrading Update
14th Sep 20175:34 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSTrading Update and Interim Results Date
18th Jul 20177:00 amRNSRegulatory Approval for TruBrand Materials, China
7th Jul 20177:08 amRNSHolding(s) in Company
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.